Approvals/NMPA/Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets (15mg/500mg)

Approved

化学药品

Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets (15mg/500mg)

北京北陆药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8pdWeVCW8Op
Approval Number: 国药准字H20256205
Generic Name: 吡格列酮二甲双胍片
Generic Name En: Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets (15mg/500mg)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含盐酸吡格列酮15mg（以C₁₉H₂₀N₂O₃S计）和盐酸二甲双胍500mg
Reg Date: 2025-12-09
Company Name: 北京北陆药业股份有限公司
Company Address: 北京市密云区水源西路3号
Production Company Name: 浙江赛默制药有限公司
Production Company Address: 浙江省金华市婺城区汤溪镇永湖街788号
Company Detail Path: /organization/beijing-beilu-pharmaceutical-co-ltd
Production Company Detail Path: /organization/zhe-jiang-sai-mo-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 9, 2025

Approval ID

8pdWeVCW8Op

Type

化学药品